Skip to main content

KPV vs MOTS-c

A detailed comparison to help you understand the differences and choose the right peptide for your research goals.

KPV

KPV is a tripeptide (Lys-Pro-Val) derived from alpha-melanocyte-stimulating hormone (α-MSH). It retains the potent anti-inflammatory properties of the parent hormone without the tanning or other melanocortin effects.

Full details →

MOTS-c

MOTS-c (Mitochondrial Open Reading Frame of the Twelve S rRNA type-c) is a mitochondrial-derived peptide that plays a key role in metabolic regulation and has emerged as a significant longevity research target.

Full details →

Side-by-Side Comparison

AspectKPVMOTS-c
Dose Range200 mcg–500 mcg5 mg–10 mg
Frequency1x dailyLess than daily
Cycle Length4–8 weeks8–12 weeks
Routesubcutaneoussubcutaneous
MechanismInhibits NF-κB activation and reduces inflammatory cytokine production. Enters cells and directly modulates inflammatory signaling without requiring melanocortin receptors.Activates AMPK pathway, enhances glucose uptake in skeletal muscle, improves insulin sensitivity, and regulates mitochondrial function. Acts as a metabolic hormone affecting whole-body energy homeostasis.
Typical DosageOral/sublingual: 200-500mcg 1-3 times daily. Topical formulations for localized inflammation. Also used in enemas for gut inflammation.Research protocols typically use 5-10mg administered subcutaneously several times per week. Optimal dosing not yet established.
AdministrationCan be taken orally, sublingually, or as suppositories/enemas for gut inflammation. Topical use for skin conditions. Stable orally unlike most peptides.Subcutaneous injection. Often combined with exercise protocols as it enhances exercise capacity and metabolic adaptation.
Side EffectsGenerally very well-tolerated. Minimal systemic effects due to targeted anti-inflammatory action.Limited human data. Animal studies show good tolerability. May affect energy levels and exercise performance.
Best For

Key Differences

Key Studies

Ready to Learn More?